More Big Deals for Health Care Eyed in 2022
As M&A investments could hit $400 billion this year, watch for buys in health technology and data, biotech, pharma and medical devices.
Zoetis Could Be Seeing Its Correction Coming to an End
The shares of the animal health company could be finding a bottom after losing substantial ground since the start of the year.
Dexcom's Charts Don't Make a Convincing Case for Its Shares
The stock of the maker of glucose monitoring systems may be seeking a bottom but it isn't clear whether it has gotten there yet.
Walgreens Boots Alliance Is Ready to Break Out of Its Lengthy Consolidation
Here's where traders could go long.
Cigna's Charts Continue on Healthy Course
Here's how to approach CI after our Dec. 21 recommendation.
HCA Is Likely to Bring Healthy Profits to Your Portfolio in 2022
The hospital operator sports favorable technical signals going into the New Year.
This Medical Device Maker Should Pick Up the Pace in 2022
Here's why down-and-out Medtronic could see a good year ahead.
Here's Our Best Dividend Stock for 2022
Blue chip stock Bristol-Myers Squibb has a high dividend yield and an excellent pipeline.
Anthem Sports Healthy-Looking Charts as It Gains Higher Ground
We're setting new price targets for the health insurer as its technical signals remain largely bullish.
Cigna Rallies Despite an Analyst Downgrade: What Gives?
Pay attention when a stock does not decline on what is perceived as bearish news.